Table III.
Calculation of Ketoprofen Dose Number for Individual Patients Reported in Kokki et al. (10)
Subject | Age (month) |
Weight (kg) |
Height (cm) | BSA-derived volume (ml) | Dose (mg) |
Dose number |
---|---|---|---|---|---|---|
11 | 16 | 12 | 84 | 76.5 | 12.5 | 0.907 |
12 | 52 | 17 | 100 | 99.3 | 12.6 | 0.704 |
13 | 22 | 15 | 89 | 88.0 | 12.5 | 0.786 |
14 | 35 | 15 | 95 | 90.9 | 12.5 | 0.761 |
15 | 61 | 20 | 111 | 113.5 | 25.0 | 1.22 |
16 | 54 | 19 | 110 | 110 | 25.1 | 1.27 |
17 | 59 | 23 | 115 | 124 | 25.1 | 1.12 |
18 | 25 | 12 | 88 | 78.3 | 12.5 | 0.886 |
19 | 69 | 17 | 111 | 104 | 12.6 | 0.668 |
20 | 69 | 18 | 114 | 109 | 25.0 | 1.27 |
Subject age, weight, height and dose were obtained from the article to calculate BSA-derived pediatric reference volume. Dose numbers for each infant and child reflected high solubility when dose was low (i.e., 12 mg) and low solubility when the dose was high (i.e., 25 mg). Dose number values here were approximately one, in agreement with the general approach (Table II)